HIV Drugs Market is projected to reach US$ 71.03 Billion by 2033
The global HIV Drugs Market is expanding steadily as pharmaceutical companies and healthcare systems worldwide advance antiretroviral therapies to improve treatment outcomes and patient adherence. HIV drugs, spanning integrase inhibitors, combination medicines, and long-acting formulations, continue to evolve as manufacturers address the challenges of lifelong treatment through simplified regimens and extended dosing intervals. Rising HIV … Read more